Aggressive Surgery Increases Survival with Low-Grade Brain Tumors | UC San Francisco
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink
Brain Tumour Registry of Canada (BTRC): Survival and Prevalence Report 2010–2017 June 2022
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Astrocytoma Tumors – Symptoms, Diagnosis and Treatments
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study
Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in Survival Outcomes
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram
Advantages of gross total resection in patients with astrocytoma: A population‑based study
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas - Modern Pathology
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas - ScienceDirect
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports
Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy